1081002

Butalbital

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): 5-Allyl-5-isobutylbarbituric acid
• Empirical Formula (Hill Notation): C₁₁H₁₆N₂O₃
• CAS Number: 77-26-9
• Molecular Weight: 224.26
• UNSPSC Code: 41116107
• NACRES: NA.24
• PubChem Substance ID: 329749167
• MDL number: MFCD00056089
• Beilstein/REAXYS Number: 202119

Properties

• grade: pharmaceutical primary standard
• agency: USP
• API family: butalbital
• manufacturer/tradename: USP
• drug control: USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal); Pszichotróp anyag / Psychotropic Substance (Hungary), 78/2022. (XII. 28.) BM rendelet, kontrollierte Droge in Deutschland
• application(s): pharmaceutical; pharmaceutical (small molecule)
• format: neat
• SMILES string: CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O
• InChI: 1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)
• InChI key: UZVHFVZFNXBMQJ-UHFFFAOYSA-N
• Gene Information: human ... GABRA1(2554), GABRA2(2555), GABRA3(2556), GABRA4(2557), GABRA5(2558), GABRA6(2559), GABRB1(2560), GABRB2(2561), GABRB3(2562), GABRD(2563), GABRE(2564), GABRG1(2565), GABRG2(2566), GABRG3(2567), GABRP(2568), GABRQ(55879)

Description

General description

Find answers to frequently asked questions on USP products in USP FAQs.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Butalbital USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Butalbital, Aspirin, and Caffeine Capsules
• Butalbital, Aspirin, and Caffeine Tablets
• Butalbital, Acetaminophen, and Caffeine Tablets
• Butalbital, Acetaminophen, and Caffeine Capsules
• Butalbital, Aspirin, Caffeine, and Codeine Phosphate Capsules

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Legal Information

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.

Safety Information

• Pictograms: GHS07
• Signal Word: Warning
• Hazard Codes: H302,H317
• Precautionary Statements: P280 - P301 + P312 + P330
• Hazard Classifications: Acute Tox. 4 Oral - Skin Sens. 1
• Storage Class: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable